Greg Keenan

CIK: 0002044006

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

JSPR

Jasper Therapeutics, Inc.

Officer

AUPH

Aurinia Pharmaceuticals Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

AUPH
Aurinia Pharmaceuticals Inc.
Mar 6, 2026
Tax Payment(F)
Direct
8.1K shares at avg. $14.32$116K
AUPH
Aurinia Pharmaceuticals Inc.
Feb 27, 2026
Award(A)
Direct
40.6K shares-
AUPH
Aurinia Pharmaceuticals Inc.
Feb 2, 2026
Tax Payment(F)
Direct
11.6K shares at avg. $14.53$168K
AUPH
Aurinia Pharmaceuticals Inc.
Aug 1, 2025
Sale(S)
Direct
20K shares at avg. $10.50$210K
AUPH
Aurinia Pharmaceuticals Inc.
Mar 7, 2025
Sale(S)
Direct
8.3K shares at avg. $8.23$68K
AUPH
Aurinia Pharmaceuticals Inc.
Mar 3, 2025
Sale(S)
Direct
12.2K shares at avg. $8.00$98K
AUPH
Aurinia Pharmaceuticals Inc.
Feb 28, 2025
Award(A)
Direct
62.6K shares-

		Type	Shares	Price		Ownership
Mar 6, 2026	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	8,069	$14.32	$115,548	Direct
Feb 27, 2026	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	40,586	-	$0	Direct
Feb 2, 2026	AUPH Aurinia Pharmaceuticals Inc.	Tax Payment(F)	11,552	$14.53	$167,851	Direct
Aug 1, 2025	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	20,000	$10.50	$210,000	Direct
Mar 7, 2025	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	8,305	$8.23	$68,350	Direct
Mar 3, 2025	AUPH Aurinia Pharmaceuticals Inc.	Sale(S)	12,239	$8.00	$97,912	Direct
Feb 28, 2025	AUPH Aurinia Pharmaceuticals Inc.	Award(A)	62,583	-	-	Direct

1-7 of 7 transactions

About Keenan Greg

Keenan Greg (SEC CIK 0002044006) files insider reports with the SEC as Chief Medical Officer of Jasper Therapeutics, Inc. (JSPR) and SVP, Chief Medical Officer of Aurinia Pharmaceuticals Inc. (AUPH).

Signal8 holds 8 ownership filings by Keenan Greg (2 Form 3, 6 Form 4), filed between Nov 12, 2024 and Jul 23, 2026. Those filings report 7 transactions, from Feb 28, 2025 to Mar 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Keenan Greg's filings is in EDMONTON, A0.

Recent filings by Keenan Greg

Mar 6, 2026: Tax withholding of AUPH shares (Form 4, code F).
Feb 27, 2026: Grant or award of AUPH shares (Form 4, code A).
Feb 2, 2026: Tax withholding of AUPH shares (Form 4, code F).
Aug 1, 2025: Open-market sale of AUPH shares (Form 4, code S).
Mar 7, 2025: Open-market sale of AUPH shares (Form 4, code S).

Other insiders filing for Jasper Therapeutics, Inc. (JSPR)

WIGGANS THOMAS G, Director
Lucas Svetlana, Director
Crutcher Patrick J, Director
EMSTER KURT VON, Director
Shizuru Judith Anne, Director
Ros Matthew E, Chief Operating Officer

How to read Form 4 transaction codes